Integris Neuro LLC: Company Profile

Background

Overview

Integris Neuro LLC, founded on February 18, 2019, by Steven Estes and Keith Arrants, specializes in providing advanced electroencephalography (EEG) services and neurodiagnostic solutions. With over 35 years of experience in the EEG field, Steven Estes introduced Keith Arrants to the discipline in the early 2000s, leading to their collaborative venture. The company is headquartered in Highland Village, Texas, and operates across Texas, Louisiana, and Oklahoma.

Mission and Vision

Integris Neuro's mission is to empower neurologists and healthcare providers by delivering high-quality EEG services that enhance patient care and practice efficiency. The company envisions a healthcare environment where neurologists are at the forefront, supported by innovative solutions that streamline neurodiagnostic processes.

Industry Significance

In the evolving field of neurodiagnostics, Integris Neuro stands out by offering comprehensive EEG services that address the growing demand for reliable and efficient monitoring solutions. Their focus on quality and innovation contributes significantly to the advancement of neurological care.

Key Strategic Focus

Core Objectives

Integris Neuro aims to:

• Enhance the operational efficiency of neurologists through advanced EEG services.

• Provide comprehensive monitoring solutions that improve patient outcomes.

• Support healthcare facilities in delivering high-quality neurodiagnostic care.

Areas of Specialization

The company specializes in:

• Long-term Video Ambulatory EEGs conducted in outpatient clinics.

• Continuous EEG monitoring for inpatients.

• Intermittently Monitored Video Ambulatory EEG studies.

Key Technologies Utilized

Integris Neuro employs:

• The Integris Neuro QUAD Conversion Kit for outpatient EEG studies.

• Advanced remote monitoring and annotation tools for continuous EEG services.

Primary Markets Targeted

The company serves:

• Neurology practices.

• Hospitals and healthcare facilities.

• Patients requiring neurodiagnostic evaluations.

Financials and Funding

Funding History

Specific details regarding Integris Neuro's funding history, total funds raised, recent funding rounds, and notable investors are not publicly disclosed.

Intended Utilization of Capital

While detailed plans for capital utilization are not publicly available, it is reasonable to infer that funds are directed towards:

• Research and development of innovative EEG technologies.

• Expansion of service offerings across additional regions.

• Enhancement of operational capabilities to support growing client needs.

Pipeline Development

Key Pipeline Candidates

Integris Neuro's primary focus is on:

• Developing and refining the Integris Neuro QUAD Conversion Kit.

• Expanding remote monitoring capabilities for continuous EEG services.

Stages of Development

The company is actively involved in:

• Ongoing research and development to enhance existing technologies.

• Implementing new service models to meet evolving healthcare demands.

Target Conditions

Integris Neuro's services are designed to support the diagnosis and management of various neurological conditions, including:

• Epilepsy.

• Seizure disorders.

• Other neurological disorders requiring EEG monitoring.

Anticipated Milestones

While specific timelines for upcoming milestones are not publicly disclosed, the company is expected to:

• Launch enhanced versions of their EEG monitoring technologies.

• Expand service coverage to additional states.

Technological Platform and Innovation

Proprietary Technologies

Integris Neuro has developed:

• The Integris Neuro QUAD Conversion Kit, enabling outpatient clinics to perform long-term Video Ambulatory EEGs.

Significant Scientific Methods

The company utilizes:

• Advanced remote monitoring and annotation techniques for continuous EEG services.

• Comprehensive reporting systems to support accurate and efficient diagnoses.

Leadership Team

Key Executives

• Steven Estes: President and CEO. With over 35 years in the EEG field, Steven co-founded Integris Neuro to innovate and enhance neurodiagnostic services.

• Keith Arrants: Co-Founder. Partnered with Steven to establish the company, bringing extensive experience in EEG technologies.

• Carmen Ellison: Chief Operating Officer. Oversees daily operations, ensuring the delivery of high-quality services.

• John Tran: Vice President of Technology Innovation. Leads the development and implementation of new technologies and service models.

• Darren Hall: Vice President of Sales & Marketing. Drives business growth through strategic sales initiatives and marketing efforts.

Leadership Changes

As of April 2026, there are no publicly available records of recent significant changes or appointments within Integris Neuro's leadership team.

Competitor Profile

Market Insights and Dynamics

The neurodiagnostic services market is experiencing growth due to:

• An increasing prevalence of neurological disorders.

• Advancements in EEG technology.

• A rising demand for outpatient diagnostic services.

Competitor Analysis

Integris Neuro faces competition from:

• Allegiance Ambulance: Offers a range of healthcare services, including emergency medical services.

• Advance ER: Provides emergency room services with a focus on patient convenience.

• AmerisourceBergen: A global pharmaceutical sourcing and distribution services company.

• Family Healthcare: Delivers comprehensive healthcare services to families.

• San Antonio Eye Center: Specializes in eye care and related services.

• Low T Center: Focuses on men's health, particularly testosterone therapy.

• Access Physicians: Provides telemedicine services across various specialties.

• Allen Independent School District: While primarily an educational institution, it may offer health services to students and staff.

• Women's Center of Texas: Specializes in women's health services.

• Medibid: An online marketplace for medical services.

Strategic Collaborations and Partnerships

Integris Neuro collaborates with healthcare facilities to:

• Implement EEG monitoring solutions tailored to specific needs.

• Enhance the quality and efficiency of neurodiagnostic services.

Operational Insights

Integris Neuro differentiates itself through:

• A focus on quality and patient-centered care.

• Innovative technologies that streamline EEG monitoring processes.

• A commitment to supporting neurologists and healthcare providers in delivering optimal care.

Strategic Opportunities and Future Directions

The company is well-positioned to:

• Expand its service offerings to additional regions.

• Develop new technologies that further enhance EEG monitoring capabilities.

• Strengthen partnerships with healthcare providers to improve patient outcomes.

Contact Information

• Website: www.integrisneuro.com

• Social Media: Facebook, LinkedIn